Log In
BCIQ
Print this Print this
 

TX01

  Manage Alerts
Collapse Summary General Information
Company Tanvex BioPharma Inc.
Description 
Molecular Target
Mechanism of ActionBiosimilar
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationNeutropenia
Indication DetailsTreat chemotherapy-induced neutropenia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today